The role of IL-5 in bleomycin-induced pulmonary fibrosis

被引:60
作者
Gharaee-Kermani, M
McGarry, B
Lukacs, N
Huffnagle, G
Egan, RW
Phan, SH [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
关键词
eosinophils; cytokine expression; inflammation;
D O I
10.1002/jlb.64.5.657
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Eosinophils are known to express cytokines capable of promoting fibrosis, Interleukin-5 (IL-5) is important in regulating eosinophilopoiesis, eosinophil recruitment and activation, Lung IL-5 expression is elevated in pulmonary fibrosis, wherein the eosinophil is a primary source of fibrogenic cytokines. To determine the role of IL-5 in pulmonary fibrosis, the effects of anti-IL-5 antibody were investigated in a model of bleomycin-induced pulmonary fibrosis, Fibrosis was induced in mice by endotracheal bleomycin treatment. Animals were also treated with either anti-IL-5 antibody or control IgG, Lungs were then analyzed for fibrosis, eosinophil influx, chemotactic activity, and cytokine expression, The results show that a primary chemotactic activity at the height of eosinophil recruitment is IL-5, Furthermore, anti-IL-5 antibody caused significant reduction in lung eosinophilia, cytokine expression, and fibrosis, These findings taken together suggest an important role for IL-5 in pulmonary fibrosis via its ability to regulate eosinophilic inflammation, and thus eosinophil-dependent fibrogenic cytokine production.
引用
收藏
页码:657 / 666
页数:10
相关论文
共 68 条
[1]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[2]  
CAMPANA D, 1987, J IMMUNOL, V138, P648
[3]   ANTI-IL-5 MONOCLONAL-ANTIBODY INHIBITS ALLERGIC LATE PHASE BRONCHIAL EOSINOPHILIA IN GUINEA-PIGS - A THERAPEUTIC APPROACH [J].
CHAND, N ;
HARRISON, JE ;
ROONEY, S ;
PILLAR, J ;
JAKUBICKI, R ;
NOLAN, K ;
DIAMANTIS, W ;
SOFIA, RD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (01) :121-123
[4]   THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[5]   ANTIBODY TO INTERLEUKIN-5 INHIBITS HELMINTH-INDUCED EOSINOPHILIA IN MICE [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
HUDAK, S ;
JACKSON, J ;
RENNICK, D .
SCIENCE, 1989, 245 (4915) :308-310
[6]   COOPERATION BETWEEN INTERLEUKIN-5 AND THE CHEMOKINE EOTAXIN TO INDUCE EOSINOPHIL ACCUMULATION IN-VIVO [J].
COLLINS, PD ;
MARLEAU, S ;
GRIFFITHSJOHNSON, DA ;
JOSE, PJ ;
WILLIAMS, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1169-1174
[7]   EOSINOPHILIA IN TRANSGENIC MICE EXPRESSING INTERLEUKIN-5 [J].
DENT, LA ;
STRATH, M ;
MELLOR, AL ;
SANDERSON, CJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1425-1431
[8]  
DERYNCK R, 1986, J BIOL CHEM, V261, P4377
[9]   INTERLEUKIN-5 MESSENGER-RNA EXPRESSION BY EOSINOPHILS IN THE INTESTINAL-MUCOSA OF PATIENTS WITH CELIAC-DISEASE [J].
DESREUMAUX, P ;
JANIN, A ;
COLOMBEL, JF ;
PRIN, L ;
PLUMAS, J ;
EMILIE, D ;
TORPIER, G ;
CAPRON, A ;
CAPRON, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :293-296
[10]   QUANTITATION OF MAST-CELLS AND EOSINOPHILS IN THE BRONCHIAL-MUCOSA OF SYMPTOMATIC ATOPIC ASTHMATICS AND HEALTHY CONTROL SUBJECTS USING IMMUNOHISTOCHEMISTRY [J].
DJUKANOVIC, R ;
WILSON, JW ;
BRITTEN, KM ;
WILSON, SJ ;
WALLS, AF ;
ROCHE, WR ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (04) :863-871